| COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study J Avouac, E Drumez, E Hachulla, R Seror, S Georgin-Lavialle, ... The Lancet Rheumatology 3 (6), e419-e426, 2021 | 259 | 2021 |
| Infliximab versus adalimumab in the treatment of refractory inflammatory uveitis: a multicenter study from the French Uveitis Network H Vallet, P Seve, L Biard, J Baptiste Fraison, P Bielefeld, L Perard, ... Arthritis & rheumatology 68 (6), 1522-1530, 2016 | 154 | 2016 |
| Recent data on the role for angiogenesis in rheumatoid arthritis G Clavel, N Bessis, MC Boissier Joint Bone Spine 70 (5), 321-326, 2003 | 133 | 2003 |
| Angiogenesis markers (VEGF, soluble receptor of VEGF and angiopoietin-1) in very early arthritis and their association with inflammation and joint destruction G Clavel, N Bessis, D Lemeiter, P Fardellone, O Mejjad, JF Ménard, ... Clinical Immunology 124 (2), 158-164, 2007 | 132 | 2007 |
| Severity of COVID-19 and survival in patients with rheumatic and inflammatory diseases: data from the French RMD COVID-19 cohort of 694 patients FAI2R/SFR/SNFMI/SOFREMIP/CRI/IMIDIATE consortium and contributors Annals of the Rheumatic Diseases 80 (4), 527-538, 2021 | 90 | 2021 |
| Musculoskeletal ultrasonography in healthy subjects and ultrasound criteria for early arthritis (the ESPOIR cohort) F Millot, G Clavel, F Etchepare, F Gandjbakhch, F Grados, A Saraux, ... The Journal of rheumatology 38 (4), 613-620, 2011 | 74 | 2011 |
| Blood vessels, a potential therapeutic target in rheumatoid arthritis? L Semerano, G Clavel, E Assier, A Denys, MC Boissier Joint Bone Spine 78 (2), 118-123, 2011 | 68 | 2011 |
| Interleukin newcomers creating new numbers in rheumatology: IL-34 to IL-38 G Clavel, A Thiolat, MC Boissier Joint bone spine 80 (5), 449-453, 2013 | 67 | 2013 |
| Developments with investigational Janus kinase inhibitors for rheumatoid arthritis L Semerano, P Decker, G Clavel, MC Boissier Expert Opinion on Investigational Drugs 25 (12), 1355-1359, 2016 | 66 | 2016 |
| Relationship between angiogenesis and inflammation in experimental arthritis G Clavel, C Valvason, K Yamaoka, D Lemeiter, L Laroche, MC Boissier, ... European cytokine network 17 (3), 202-210, 2006 | 66 | 2006 |
| Osteoarticular side effects of BCG therapy G Clavel, F Grados, P Lefauveau, P Fardellone Joint Bone Spine 73 (1), 24-28, 2006 | 53 | 2006 |
| Polyarthritis following intravesical BCG immunotherapy G Clavel, F Grados, G Cayrolle, R Bellony, I Leduc, B Lafont, JP Ducroix, ... Rev Rheum Engl Ed 66, 115-18, 1999 | 51 | 1999 |
| Ultrasound and Doppler micro-imaging in a model of rheumatoid arthritis in mice G Clavel, C Marchiol-Fournigault, G Renault, MC Boissier, D Fradelizi, ... Annals of the rheumatic diseases 67 (12), 1765-1772, 2008 | 48 | 2008 |
| Targeting IL-6 for the treatment of rheumatoid arthritis: Phase II investigational drugs L Semerano, A Thiolat, E Minichiello, G Clavel, N Bessis, MC Boissier Expert opinion on investigational drugs 23 (7), 979-999, 2014 | 44 | 2014 |
| Increased diagnostic accuracy of giant cell arteritis using three-dimensional fat-saturated contrast-enhanced vessel-wall magnetic resonance imaging at 3 T G Poillon, A Collin, Y Benhamou, G Clavel, J Savatovsky, C Pinson, ... European radiology 30, 1866-1875, 2020 | 35 | 2020 |
| Involvement of Tumor Necrosis Factor Receptor Type II in FoxP3 Stability and as a Marker of Treg Cells Specifically Expanded by Anti–Tumor Necrosis Factor … F Santinon, M Batignes, ML Mebrek, J Biton, G Clavel, R Hervé, ... Arthritis & Rheumatology 72 (4), 576-587, 2020 | 31 | 2020 |
| Progressive multifocal leukoencephalopathy and rheumatoid arthritis treatments G Clavel, A Moulignier, L Semerano Joint Bone Spine 84 (6), 671-675, 2017 | 31 | 2017 |
| Three Tesla 3D high-resolution vessel wall MRI of the orbit may differentiate arteritic from nonarteritic anterior ischemic optic neuropathy N Mohammed-Brahim, G Clavel, F Charbonneau, L Duron, H Picard, ... Investigative Radiology 54 (11), 712-718, 2019 | 28 | 2019 |
| Management of severe and refractory Mooren's ulcers with rituximab D Guindolet, C Reynaud, G Clavel, G Belangé, M Benmahmed, S Doan, ... British Journal of Ophthalmology 101 (4), 418-422, 2017 | 26 | 2017 |
| Is it possible to identify early predictors of the future cost of chronic arthritis? The VErA project E Flipon, M Brazier, G Clavel, P Boumier, A Gayet, X Le Loét, ... Fundamental & clinical pharmacology 23 (1), 105-113, 2009 | 26 | 2009 |
